vTv Therapeutics Inc. - (VTVT): Price and Financial Metrics

vTv Therapeutics Inc. - (VTVT): $2.68

0.01 (+0.37%)

POWR Rating

Component Grades














  • VTVT scores best on the Growth dimension, with a Growth rank ahead of 78.72% of US stocks.
  • VTVT's strongest trending metric is Momentum; it's been moving down over the last 31 weeks.
  • VTVT ranks lowest in Stability; there it ranks in the 3rd percentile.

VTVT Stock Summary

  • The capital turnover (annual revenue relative to shareholder's equity) for VTVT is -0.13 -- better than only 6.33% of US stocks.
  • With a year-over-year growth in debt of -85.11%, vTv Therapeutics Inc's debt growth rate surpasses just 2.64% of about US stocks.
  • As for revenue growth, note that VTVT's revenue has grown 299.41% over the past 12 months; that beats the revenue growth of 97.66% of US companies in our set.
  • If you're looking for stocks that are quantitatively similar to vTv Therapeutics Inc, a group of peers worth examining would be IDYA, MARK, KIQ, ARPO, and LPTX.
  • Visit VTVT's SEC page to see the company's official filings. To visit the company's web site, go to www.vtvtherapeutics.com.

VTVT Price Target

For more insight on analysts targets of VTVT, see our VTVT price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $6.75 Average Broker Recommendation 1.5 (Moderate Buy)

VTVT Stock Price Chart Interactive Chart >

Price chart for VTVT

VTVT Price/Volume Stats

Current price $2.68 52-week high $4.75
Prev. close $2.67 52-week low $1.44
Day low $2.64 Volume 3,582,100
Day high $2.88 Avg. volume 4,884,301
50-day MA $2.56 Dividend yield N/A
200-day MA $2.24 Market Cap 217.37M

vTv Therapeutics Inc. - (VTVT) Company Bio

vTv Therapeutics Inc., a biopharmaceutical company, discovers, develops, and sells orally administered small molecule drug candidates worldwide. The company was founded in 2015 and is based in High Point, North Carolina.

VTVT Latest News Stream

Event/Time News Detail
Loading, please wait...

VTVT Latest Social Stream

Loading social stream, please wait...

View Full VTVT Social Stream

Latest VTVT News From Around the Web

Below are the latest news stories about vTv Therapeutics Inc that investors may wish to consider to help them evaluate VTVT as an investment opportunity.

Alzheimer's Disease Pipeline Report: Current Therapies, Emerging Drugs, and Treatment Outlook

Los Angeles, USA, May 31, 2021 (GLOBE NEWSWIRE) -- Alzheimer's Disease Pipeline Report: Current Therapies, Emerging Drugs, and Treatment Outlook Alzheimer's Disease pipeline shows progress in the clinical trials with the upcoming therapies such as BAN2401, Gantenerumab, Bryostatin-1, INB03, AZT-211, and others. DelveInsight's " Alzheimer's Disease Pipeline Insight " report provides comprehensive insights about 150+ companies and 150+ pipeline drugs in the Alzheimer's Disease pipeline landscapes. It comprises Alzheimer's Disease pipeline drug profiles, including clinical and non-clinical stage products. It also includes the Alzheimer's Disease therapeutics assessment by product type, stage, route of administration, and molecule type and further highlights the inactive Alzheimer's Disease...

Benzinga | May 31, 2021

What Kind Of Shareholders Own vTv Therapeutics Inc. (NASDAQ:VTVT)?

The big shareholder groups in vTv Therapeutics Inc. ( NASDAQ:VTVT ) have power over the company. Large companies...

Yahoo | May 25, 2021

4 Up-and-Coming Stocks to Buy in Shifting Sectors

vTv Therapeutics, Arrival, PubMatic, and Schrodinger are four up-and-coming stocks to buy.

Larry Ramer on InvestorPlace | April 27, 2021

Today’s Biggest Pre-Market Movers: 10 Top Gainers and Losers on Friday Morning

The weekend is almost here but investors have one more day of trading and we're helping out with the biggest pre-market movers for Friday.

William White on InvestorPlace | April 16, 2021

VTVT Stock: The FDA News Sending vTv Therapeutics Soaring Today

Today, VTVT stock is on the move as investors price in a key announcement from the FDA designating a leading drug a breakthrough therapy.

Chris MacDonald on InvestorPlace | April 13, 2021

Read More 'VTVT' Stories Here

VTVT Price Returns

1-mo 14.53%
3-mo -3.25%
6-mo -9.76%
1-year -2.76%
3-year 58.58%
5-year -53.47%
YTD 44.09%
2020 9.41%
2019 -35.85%
2018 -55.91%
2017 24.43%
2016 -29.07%

Continue Researching VTVT

Want to see what other sources are saying about vTv Therapeutics Inc's financials and stock price? Try the links below:

vTv Therapeutics Inc (VTVT) Stock Price | Nasdaq
vTv Therapeutics Inc (VTVT) Stock Quote, History and News - Yahoo Finance
vTv Therapeutics Inc (VTVT) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!

Page generated in 0.8864 seconds.